| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.884 | 12.433 | 15.582 | 3.780 | 2.165 | 1.477 | 2.074 | 1.004 | 0 | 0 |
| Total Income - EUR | 26.886 | 12.433 | 15.582 | 3.780 | 17.489 | 13.537 | 3.274 | 1.004 | 0 | 0 |
| Total Expenses - EUR | 11.526 | 11.063 | 6.224 | 3.462 | 17.181 | 12.270 | 2.556 | 456 | 0 | 0 |
| Gross Profit/Loss - EUR | 15.360 | 1.371 | 9.358 | 317 | 307 | 1.267 | 718 | 548 | 0 | 0 |
| Net Profit/Loss - EUR | 14.553 | 998 | 8.890 | 204 | 242 | 1.227 | 660 | 518 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Exigia Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 20.041 | 17.983 | 19.010 | 14.755 | 29.805 | 17.656 | 15.924 | 16.464 | 16.414 | 10.996 |
| Inventories | 0 | 225 | 5.526 | 5.425 | 5.319 | 5.219 | 5.103 | 5.119 | 5.103 | 0 |
| Receivables | 1.488 | 876 | 861 | 1.844 | 2.514 | 815 | 2.304 | 830 | 828 | 572 |
| Cash | 18.553 | 16.881 | 12.623 | 7.486 | 21.972 | 11.622 | 8.518 | 10.515 | 10.483 | 10.425 |
| Shareholders Funds | 17.460 | 15.935 | 14.675 | 14.609 | 14.569 | 15.520 | 15.836 | 16.403 | 16.353 | 10.936 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 2.582 | 2.047 | 4.335 | 146 | 1.726 | 942 | 88 | 61 | 61 | 60 |
| Income in Advance | 0 | 0 | 0 | 0 | 13.510 | 1.194 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
6209
|
|||||||||
Comments - Exigia Medical Srl